Stereotactic arrhythmia radiotherapy for ventricular tachycardia does not appear to alter QRS duration and QTc interval: a secondary analysis of the prospective STARNL-1 trial

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Foundation. Main funding source(s): Dutch Heart Foundation grant to dr. P.G. Postema, MD PhD BACKGROUND: Stereotactic arrhythmia radiotherapy (STAR) has evolved as promising bail-out treatment in patients with therapy-refractory ventricular tachycar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoeksema, W F, Van Der Ree, M H, Dieleman, E M T, Visser, J, Planken, R N, De Bruin-Bon, R H A, De Jong, R M A J, Kemme, M J B, Balt, J C, Balgobind, B V, Postema, P G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
13.4.3 - Ablation of Ventricular Arrhythmias
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207262/
http://dx.doi.org/10.1093/europace/euad122.337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207262/
http://dx.doi.org/10.1093/europace/euad122.337

Ejemplares similares